Login / Signup

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.

Anchalee AvihingsanonPloenchan ChetchotisakdSasisopin KiertiburanakulWinai RatanasuwanKrittaecho SiripassornKhuanchai SupparatpinyoHal MartinHui WangTinHung WongHsiu Yin Wang
Published in: HIV medicine (2022)
ClinicalTrials.gov (NCT02603120, NCT02652624, and NCT02603107).
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • hiv infected
  • double blind
  • phase ii
  • hiv infected patients
  • placebo controlled
  • antiretroviral therapy
  • study protocol